Home
Journal Information
About
Aims and Scope
Contacts and Editorial Office
Editorial Board
Editor in Chief
Publisher
Conflicts of Interest
Editorial Policies
Publication Ethics
Nickan Research Institute policy
DISCLAIMER
Open Access
Journal Issues
Current Issue
In Press
Archive
Guidelines
For Authors
For Authors-New
For Reviewers
Peer Review Process in JRIP
Peer Review Process flowchart in JRIP
Authors agreement form
Checklist for review
Editorial Workflow
Publication Ethics and Malpractice Statement
Human and animal right
Informed Consent
Create Account
Login
Please don't use dangerous characters
Title
Author
Abstract
Keywords
First Name
Last Name
Search
eISSN
:
2345-2781
Submit Your Paper
Editorial Board
Aims and Scope
Publisher
Publication Fee
Contact Us
Archive
Indexing Information
Member of
Follower of
2013, Volume 2, Issue 3
×
Journal of Renal Injury Prevention
Chief Editor: Azar Baradaran
Editorial
Cisplatin and renal injury; current concepts
Hamid Nasri*
J Renal Inj Prev
. 2013;2(3): 89-90.
doi:
10.12861/jrip.2013.28
PMCID:
PMC4206018
PMID:
25340137
Article
PDF
XML
Cited By:
6
×
Cisplatin and renal injury; current concepts
Editorial
Metformin and renal injury protection
Mahmoud Rafieian-Kopaie*
J Renal Inj Prev
. 2013;2(3): 91-92.
doi:
10.12861/jrip.2013.29
PMCID:
PMC4206022
PMID:
25340138
Article
PDF
XML
Cited By:
12
×
Metformin and renal injury protection
Short Communication
Impact of inflammation on anemia of hemodialysis patients who were under treatment of recombinant human erythropoietin
Mahmoud Rafiean-Kopaie*, Hamid Nasri
J Renal Inj Prev
. 2013;2(3): 93-95.
doi:
10.12861/jrip.2013.30
PMCID:
PMC4206023
PMID:
25340139
Article
PDF
XML
Cited By:
4
×
Impact of inflammation on anemia of hemodialysis patients who were under treatment of recombinant human erythropoietin
Original Article
AT2R -1332 G:A polymorphism and diabetic nephropathy in type 2 diabetes mellitus patients
Zohreh Rahimi, Omid Mansouri Zaveleh, Ziba Rahimi, Ardeshir Abbasi
J Renal Inj Prev
. 2013;2(3): 97-101.
doi:
10.12861/jrip.2013.31
PMCID:
PMC4206021
PMID:
25340140
Article
PDF
XML
Cited By:
12
×
AT2R -1332 G:A polymorphism and diabetic nephropathy in type 2 diabetes mellitus patients
Epidemiology and Prevention
Anemia in lupus nephritis; etiological profile
Mohammad-Reza Ardalan*
J Renal Inj Prev
. 2013;2(3): 103-104.
doi:
10.12861/jrip.2013.32
PMCID:
PMC4206024
PMID:
25340141
Article
PDF
XML
Cited By:
0
×
Anemia in lupus nephritis; etiological profile
Hypothesis
Significance of hyperuricemia in immunoglobulin A nephropathy
Hamid Nasri*, Mohammad Reza Ardalan
J Renal Inj Prev
. 2013;2(3): 105-106.
doi:
10.12861/jrip.2013.33
PMCID:
PMC4206020
PMID:
25340142
Article
PDF
XML
Cited By:
2
×
Significance of hyperuricemia in immunoglobulin A nephropathy
Renal Biopsy Teaching Point
Contrast induced nephropathy has to be differentiated from kidney injury due to atheroembolic disease
Hamid Nasri, Muhammed Mubarak*
J Renal Inj Prev
. 2013;2(3): 107-108.
doi:
10.12861/jrip.2013.34
PMCID:
PMC4206019
PMID:
25340143
Article
PDF
XML
Cited By:
4
×
Contrast induced nephropathy has to be differentiated from kidney injury due to atheroembolic disease
Letter to Editor
Ticlopidine to prevent primary arteriovenous fistula failure in hemodialysis patients; a randomized controlled trial
Ali Ghorbani*, Farzad Jasemi-Zergani
J Renal Inj Prev
. 2013;2(3): 109-111.
doi:
10.12861/jrip.2013.35
PMCID:
PMC4206025
PMID:
25340144
Article
PDF
XML
Cited By:
2
×
Ticlopidine to prevent primary arteriovenous fistula failure in hemodialysis patients; a randomized controlled trial